Aldose reductase in diabetic microvascular complications.

Most long-term diabetic patients develop microvascular diseases such as retinopathy, nephropathy and neuropathy. Although tight control of blood glucose greatly reduces the incidence of these complications, a significant fraction of diabetic patients with good glycemic control still develop these diseases. Therefore, it is imperative to understand the underlying mechanisms of these diseases such that effective treatment or preventive methods can be developed to augment euglycemic control. In animal studies, there is strong evidence that aldose reductase, the first and rate-limiting enzyme of the polyol pathway that converts glucose to fructose, plays a key role in the pathogenesis of microvascular complications. However, clinical trials of the aldose reductase inhibitors were disappointing and several pharmaceutical companies had abandoned the development of this line of drugs. In this review, the potential pathogenic mechanisms of the polyol pathway are presented, the evidence for the involvement of the polyol pathway in diabetic complications summarized, and the reasons for the unimpressive results of the clinical trials of the aldose inhibitors discussed. It appears that renewed efforts to develop aldose reductase inhibitors for the treatment and prevention of diabetic complications are warranted.
AuthorsS S M Chung, S K Chung
JournalCurrent drug targets (Curr Drug Targets) Vol. 6 Issue 4 Pg. 475-86 (Jun 2005) ISSN: 1389-4501 [Print] Netherlands
PMID16026266 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Review)
Chemical References
  • Enzyme Inhibitors
  • Extracellular Matrix Proteins
  • Polymers
  • polyol
  • Aldehyde Reductase
  • Protein Kinase C
  • Aldehyde Reductase (antagonists & inhibitors, physiology)
  • Animals
  • Diabetic Angiopathies (enzymology, etiology)
  • Diabetic Retinopathy (enzymology, etiology)
  • Enzyme Inhibitors (therapeutic use)
  • Extracellular Matrix Proteins (metabolism)
  • Glycosylation
  • Humans
  • Osmotic Pressure
  • Oxidative Stress
  • Polymers (metabolism)
  • Protein Kinase C (physiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: